Page last updated: 2024-10-22

anastrozole and Glomerulosclerosis, Focal Segmental

anastrozole has been researched along with Glomerulosclerosis, Focal Segmental in 1 studies

Glomerulosclerosis, Focal Segmental: A clinicopathological syndrome or diagnostic term for a type of glomerular injury that has multiple causes, primary or secondary. Clinical features include PROTEINURIA, reduced GLOMERULAR FILTRATION RATE, and EDEMA. Kidney biopsy initially indicates focal segmental glomerular consolidation (hyalinosis) or scarring which can progress to globally sclerotic glomeruli leading to eventual KIDNEY FAILURE.

Research Excerpts

ExcerptRelevanceReference
"Anastrozole is a selective aromatase inhibitor and is used for the hormonal treatment of postmenopausal breast cancer."7.74Anastrozole-associated sclerosing glomerulonephritis in a patient with breast cancer. ( Akgul, B; Camci, C; Kalender, ME; Karakok, M; Sevinc, A; Turk, HM, 2007)
"Anastrozole is a selective aromatase inhibitor and is used for the hormonal treatment of postmenopausal breast cancer."3.74Anastrozole-associated sclerosing glomerulonephritis in a patient with breast cancer. ( Akgul, B; Camci, C; Kalender, ME; Karakok, M; Sevinc, A; Turk, HM, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kalender, ME1
Sevinc, A1
Camci, C1
Turk, HM1
Karakok, M1
Akgul, B1

Other Studies

1 other study available for anastrozole and Glomerulosclerosis, Focal Segmental

ArticleYear
Anastrozole-associated sclerosing glomerulonephritis in a patient with breast cancer.
    Oncology, 2007, Volume: 73, Issue:5-6

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Atrophy; Breast Neoplasms; Fatal Outcome; Female

2007